Kadcyla Articles
US FDA approves Roche's late-stage breast cancer drug Kadcyla
25 February 2013
Growing patient population to drive Mexican breast cancer market
20 February 2013
Showing 1-2 of 2 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
